Photocure ASA: Annual Report 2021
Oslo, Norway, 6 April 2022: Photocure ASA today announces the publication of the Annual Report 2021, included the ESG report for 2021.
The Board of Directors of Photocure ASA has approved the annual accounts for 2021. The financial statements and annual report for the financial year 2021 are together with the ESG report and auditor's report attached to this notice. The ESEF file for 2021 is also attached.
The documents are enclosed and also made available at the company's website under [https://photocure.com/investors-hub/investors-events-and-presentations].
For further information, please contact: About Photocure ASA:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com. All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA. This information is subject to the disclosure requirements pursuant to sections 5-12 of the Norwegian Securities Trading Act.